Abstract 303: Adoption of the Novel Oral Anticoagulant Dabigatran in Patients with Atrial Fibrillation Receiving Warfarin in Community Practice: Findings from ORBIT AF [Poster Session III]

Conclusions: Patients receiving warfarin who were switched to dabigatran were younger, with lower CHADS2 scores, better kidney function, and less concomitant cardiovascular disease than those not switched. This conservative transition pattern suggests greater physician emphasis on bleeding avoidance than on stroke risk reduction.

Source: Circulation: Cardiovascular Quality and Outcomes - May 15, 2013 Category: Cardiology Authors: Holmes, D. N., Steinberg, B. A., Piccini, J. P., Ansell, J., Chang, P., Fonarow, G. C., Gersh, B., Mahaffey, K., Kowey, P., Thomas, L., Peterson, E. D., Hylek, E. Tags: Poster Session III Source Type: research